Klaus Wethmar
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.
Journal: Haematologica
Published: April 20, 2026
Prognostic impact of WBC kinetics after induction therapy in patients with acute myeloid leukemia (AML).
Journal: Leukemia & lymphoma
Published: June 02, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia.
Journal: Bone marrow transplantation
Published: June 01, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.
Journal: Blood
Published: September 10, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123).
Journal: Journal of cancer research and clinical oncology
Published: July 24, 2024
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2023
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis.
Journal: EJHaem
Published: August 07, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.
Journal: International journal of molecular sciences
Published: June 30, 2023
Last Updated: 09/26/2026